Company Filing History:
Years Active: 2022-2025
Title: Jing Wang: Innovator in Cancer Treatment
Introduction
Jing Wang is a notable inventor based in Lexington, MA (US), recognized for his contributions to cancer treatment through innovative therapies. With a total of 2 patents, his work focuses on the development of combination therapies that enhance the effectiveness of existing cancer treatments.
Latest Patents
Jing Wang's latest patents include a method of treating cancer that involves a phosphoinositide 3-kinase inhibitor with a zinc binding moiety. This invention provides a method for administering a compound to a subject in need of treatment, which may include a pharmaceutically acceptable salt. Additionally, his work encompasses a combination therapy that includes a PD-1 signaling inhibitor, ensuring that the compounds are administered in therapeutically effective amounts. Furthermore, he has developed a pharmaceutical composition that combines these elements with a suitable carrier or excipient.
Career Highlights
Throughout his career, Jing Wang has worked with prominent companies in the pharmaceutical industry, including Curis, Inc. and Constellation Pharmaceuticals, Inc. His experience in these organizations has contributed significantly to his expertise in developing innovative cancer therapies.
Collaborations
Jing Wang has collaborated with talented individuals in his field, including Troy David Patterson and Ze Tian. These partnerships have likely enhanced his research and development efforts in cancer treatment.
Conclusion
Jing Wang's innovative work in cancer treatment through combination therapies showcases his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving patient outcomes in oncology.